Funding · Company
Galvanize Therapeutics, Inc.
Redwood City, CABiotech & Pharma
Galvanize Therapeutics, Inc. of Redwood City, CA has disclosed $96M across 1 Form D offering filed with the SEC on Sep 11, 2025.
$96M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$96M
Form D · Sep 11, 2025 ↗
Q3 2025
· target $141M
Filing details
HeadquartersRedwood City, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001659073Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →